Physician profile
Brian Mullis
NPI 1598738437
$632,469.15
in general payments reported to CMS, 2019-2025
15 companies · $134K in 2025
The $134K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,914 · 2020: $4,837 · 2021: $113K · 2022: $93K · 2023: $128K · 2024: $157K · 2025: $134K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $284K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $73K · Consulting Fee: $43K · Travel and Lodging: $13K · Food and Beverage: $6,018 · Honoraria: $1,103 · Education: $37.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $283,719.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,737.50 |
| Consulting Fee | $43,298.25 |
| Travel and Lodging | $12,867.72 |
| Food and Beverage | $6,018.15 |
| Honoraria | $1,102.50 |
| Education | $37.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $481,638.03 | 2020-2025 | Affixus, Ncb, Persona |
| Smith+Nephew, INC. | $106,450.05 | 2019-2025 | Evos, Evos Mini, Taylor Spatial Frame |
| Orthofix Medical, INC. | $21,941.52 | 2023-2024 | Truelok, Tl-Hex Truelok Hexapod System, Fitbone |
| Ebi, LLC | $8,172.53 | 2025 | Ebi Osteogen Implantable Bone Growth Stimulator, Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System |
| Synthes Gmbh | $5,846.77 | 2021-2022 | |
| Kci USA, INC. | $3,516.07 | 2019-2020 | |
| Stryker Corporation | $1,884.15 | 2019-2025 | T2, Pangea, Axsos |
| Davol INC. | $1,102.50 | 2025 | |
| Depuy Synthes Sales INC. | $453.77 | 2023-2025 | Na, Lcp, Attune |
| Solventum Corporation | $425.00 | 2024 | Prevena, V.A.C. Veraflo |
| Paragon 28, INC. | $409.39 | 2021-2025 | Portfolio, Ankle Fracture, Baby Gorilla |
| Highridge Medical LLC | $395.53 | 2025 | Biomet Ebi Bone Healing System |
| Uoc USA INC | $188.21 | 2024 | U2, Psa, Conformity, U-Motion II and Ustar II |
| Wright Medical Technology, INC. | $28.76 | 2019-2020 | |
| Lifenet Health | $16.87 | 2024 | Allograft Vmis Delivery System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mullis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.